[go: up one dir, main page]

MX9701477A - Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia. - Google Patents

Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia.

Info

Publication number
MX9701477A
MX9701477A MX9701477A MX9701477A MX9701477A MX 9701477 A MX9701477 A MX 9701477A MX 9701477 A MX9701477 A MX 9701477A MX 9701477 A MX9701477 A MX 9701477A MX 9701477 A MX9701477 A MX 9701477A
Authority
MX
Mexico
Prior art keywords
composition
narcotic analgesic
relieve pain
analgesic
enhancer
Prior art date
Application number
MX9701477A
Other languages
English (en)
Inventor
David J Mayer
Donald D Price
Jianren Mao
John W Lyle
Original Assignee
Univ Virginia Commonwealth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia Commonwealth filed Critical Univ Virginia Commonwealth
Publication of MX9701477A publication Critical patent/MX9701477A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymerisation Methods In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La eficacia analgésica de un analgésico no narcotico tal como NSAID o acetaminofen se mejora significativamente administrado el NSAID o el acetaminoften antes de, con o después de la administracion de un mejorador de analgia que es un bloqueador receptor de NMDA no toxico y/o una substancia no toxica que bloquea por lo menos una consecuencia intracelular principal de la activacion del receptor de NMDA.
MX9701477A 1994-09-02 1995-08-29 Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia. MX9701477A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30073694A 1994-09-02 1994-09-02
US38206395A 1995-02-01 1995-02-01
PCT/US1995/010994 WO1996007412A1 (en) 1994-09-02 1995-08-29 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer

Publications (1)

Publication Number Publication Date
MX9701477A true MX9701477A (es) 1998-02-28

Family

ID=26971951

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701477A MX9701477A (es) 1994-09-02 1995-08-29 Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia.

Country Status (20)

Country Link
EP (1) EP0778770B1 (es)
JP (1) JPH10505087A (es)
KR (1) KR970705390A (es)
CN (1) CN1213753C (es)
AT (1) ATE255895T1 (es)
AU (1) AU714653B2 (es)
BR (1) BR9508671A (es)
CA (1) CA2197463A1 (es)
CZ (1) CZ60697A3 (es)
DE (1) DE69532285T2 (es)
ES (1) ES2211916T3 (es)
FI (1) FI970865L (es)
HU (1) HUT76798A (es)
MX (1) MX9701477A (es)
NO (1) NO970946L (es)
NZ (1) NZ292429A (es)
PL (1) PL319029A1 (es)
RU (1) RU2003115093A (es)
TW (1) TW449474B (es)
WO (1) WO1996007412A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
EP0906104A4 (en) * 1996-03-25 2003-12-10 Lilly Co Eli PAIN TREATMENT PROCESS
WO1998050075A1 (en) * 1997-05-07 1998-11-12 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
WO1999008670A1 (en) 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
DE69832712T2 (de) 1997-09-08 2006-06-22 Warner-Lambert Company Llc Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen
EP1047436B1 (en) * 1998-01-13 2009-10-21 Synchroneuron, LLC N-acetylhomotaurinates for use in treating hyperkinesias
US6054451A (en) * 1998-04-21 2000-04-25 Algos Pharmaceutical Corporation Analgesic composition and method for alleviating pain
JP2002538078A (ja) * 1998-11-12 2002-11-12 アルゴス ファーマシューティカル コーポレーション 痛みを治療するｎｍｄａ−ブロッカーと組み合わされたｃｏｘ−２阻害剤
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
DE102010024559A1 (de) 2010-06-22 2011-12-22 Süd-Chemie AG Verfahren zur Herstellung hydrophober Oberflächen
CN102266563A (zh) * 2011-07-13 2011-12-07 赵磊 一种复方止痛组合物及其制备方法
JP7673337B2 (ja) * 2019-11-07 2025-05-09 アリナミン製薬株式会社 医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4446140A (en) * 1981-12-10 1984-05-01 Nelson Research & Development Company Method and composition for treating mouth pain
CA1194799A (en) * 1981-12-10 1985-10-08 Eric L. Nelson Method and composition for reducing menstrual pain
AU2062892A (en) * 1991-08-16 1993-02-18 Mcneil-Ppc, Inc. Potentiation of antitussive effect of dextromethorphan

Also Published As

Publication number Publication date
TW449474B (en) 2001-08-11
EP0778770A1 (en) 1997-06-18
BR9508671A (pt) 1998-01-06
HUT76798A (en) 1997-11-28
KR970705390A (ko) 1997-10-09
NO970946L (no) 1997-04-28
RU2003115093A (ru) 2004-12-10
FI970865A0 (fi) 1997-02-28
FI970865A7 (fi) 1997-03-14
CN1158085A (zh) 1997-08-27
ATE255895T1 (de) 2003-12-15
FI970865L (fi) 1997-03-14
NO970946D0 (no) 1997-02-28
EP0778770B1 (en) 2003-12-10
DE69532285T2 (de) 2004-09-23
AU714653B2 (en) 2000-01-06
HK1006108A1 (en) 1999-02-12
WO1996007412A1 (en) 1996-03-14
CZ60697A3 (cs) 1998-02-18
JPH10505087A (ja) 1998-05-19
ES2211916T3 (es) 2004-07-16
DE69532285D1 (de) 2004-01-22
NZ292429A (en) 2000-01-28
CA2197463A1 (en) 1996-03-14
PL319029A1 (en) 1997-07-21
CN1213753C (zh) 2005-08-10
AU3460495A (en) 1996-03-27

Similar Documents

Publication Publication Date Title
ES2241055T3 (es) Composicion que contiene un anticonvulsionante para tratar el dolor neuropatico.
MX9701477A (es) Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia.
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
ES2170865T3 (es) Composicion de farmaco para aliviar el dolor.
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
CO5261517A1 (es) Composiciones farmaceuticas analgesicas que contienen buprenorfina/naloxona, buprenorfina/naltrexona o buprenorfina/nalmefen en bajas dosis
PE20001396A1 (es) Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
ECSP055840A (es) Derivados de 4 -tetrazolil-4fenilpiperidina para el tratamiento del dolor
KR870006891A (ko) 구강 위생 조성물
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
AU9551201A (en) Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic diseasestates
AR030957A1 (es) Composiciones de analgesico y glucosamina
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
PE20010331A1 (es) Una combinacion sinergetica: gabapentina y pregabalina
DE3875611D1 (de) Pharmazeutische zusammensetzungen.
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
AR043016A2 (es) Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene
KR940701249A (ko) 진통제
ES2107032T3 (es) Medicamento para la evitacion del desarrollo de tolerancia durante el tratamiento con sustancias activas que fijan a los receptores de benzodiazepinas.
MX9207168A (es) Composiciones orales para inhibir la formacion de placa y de calculos.
ES2175086T3 (es) Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.
ES2116452T3 (es) Composiciones farmaceuticas que comprenden agonistas de receptores 5ht1 y potenciadores de la absorcion.